Affective disorders and the loudness dependence of the auditory evoked potential : Serotonin and beyond

Copyright © 2024 Elsevier B.V. All rights reserved..

Identifying additional noninvasive biomarkers for affective disorders, such as unipolar major depressive disorder (MDD) and bipolar disorder (BD), could aid in the diagnosis and treatment of these prevalent and debilitating neuropsychiatric conditions. One such candidate biomarker is the loudness dependence of the auditory evoked potential (LDAEP), an event-related potential that measures responsiveness of the auditory cortex to different intensities of sound. The LDAEP has been associated with MDD and BD, including therapeutic response to particular classes of antidepressant drugs, while also correlating with several other neuropsychiatric disorders. It has been suggested that increased values of the LDAEP indicate low central serotonergic neurotransmission, further implicating this EEG measure in depression. Here, we briefly review the literature on the LDAEP in affective disorders, including its association with serotonergic signaling, as well as with that of other neurotransmitters such as dopamine. We summarize key findings on the LDAEP and the genetics of these neurotransmitters, as well as prediction of response to particular classes of antidepressants in MDD, including SSRIs versus noradrenergic agents. The possible relationship between this EEG measure and suicidality is addressed. We also briefly analyze acute pharmacologic studies of serotonin and/or dopamine precursor depletion and the LDAEP. In conclusion, the existing literature suggests that serotonin and norepinephrine may modulate the LDAEP in an opposing manner, and that this event-related marker may be of use in predicting response to chronic treatment with particular pharmacologic agents in the context of affective disorders, such as MDD and BD, including in the presence of suicidality.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:827

Enthalten in:

Neuroscience letters - 827(2024) vom: 28. März, Seite 137734

Sprache:

Englisch

Beteiligte Personen:

Fitzgerald, Paul J [VerfasserIn]

Links:

Volltext

Themen:

333DO1RDJY
Antidepressive Agents
Atypical depression
Dopamine
Event-related potentials
Journal Article
Lithium
Melancholic depression
Reboxetine
Review
Selective Serotonin Reuptake Inhibitors
Serotonin
Serotonin transporter polymorphism
VTD58H1Z2X

Anmerkungen:

Date Completed 08.04.2024

Date Revised 08.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.neulet.2024.137734

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369889231